Saad Khanani advises public and private companies and venture capital and private equity firms in the technology, life sciences, and other growth industries.

Saad helps public and private technology and life sciences companies, as well as institutional investors navigate a range of corporate transactions, including mergers and acquisitions and investments. He also advises emerging and growth companies on formation, corporate governance, securities law, and transactional matters.

Saad guides clients through complex transactions and growth initiatives with business-oriented advice. He draws upon his prior experience as the founder of an apparel business and a management consultant at McKinsey & Company — where he advised senior leadership at technology companies and federal government agencies.

Saad previously worked in Latham’s office in the United Arab Emirates with a practice focused on general corporate and technology transactions matters. In addition to his commercial work, Saad maintains a pro bono practice, and is an active contributor to Latham’s training and development, recruiting, and inclusion programs.

Saad was a James Kent Scholar and a Harlan Fiske Stone Scholar and member of the Columbia Business Law Review and the Faculty Rules Committee while attending Columbia University School of Law.

Mergers & Acquisitions

Saad's public and private mergers and acquisitions and strategic transaction practice has included advising:

Technology

  • Apex Technology Acquisition Corporation in its pending US$2 billion acquisition of AvePoint
  • Bitwise Asset Management in its acquisition of ETC Group
  • Bitwise Asset Management in its acquisition of Attestant
  • Bridgepoint Advisors in its acquisition of Calypso Technology
  • Cloudways in its acquisition by DigitalOcean
  • Coinbase’s US$2.9BN acquisition of Deribit
  • Convex Labs in acquisition by ServiceTitan
  • Duolingo in its acquisition of Gunner
  • Eigen Labs in its acquisition of Rio Network
  • eResearchTechnology in its sale to Nordic Capital
  • Evernote in its acquisition by Bending Spoons
  • Extreme Networks in its US$272 million acquisition of Aerohive Network
  • Hightower in its strategic combination with VTS
  • Integrated Device Technology in its US$250 million acquisition of GigPeak
  • IXYS in its US$750 million sale to Littelfuse
  • Joby Aviation in its US$5 billion business combination with Reinvent Technology Partners
  • Ka'ena Corporation in its acquisition by T-Mobile
  • Layr Labs on its acquisition of Rio Network.
  • Mellanox Technologies in its US$6.9 billion sale to NVIDIA Corporation
  • Meta in its strategic acquisitions of BigBox VR, Giphy, GrokStyle, Kustomer, Within, and other technology companies
  • NVentures on its investments in Evozyne, Charm Therapeutics 
  • NVIDIA in its investments in Databricks, CentMTL, Imbue, Hugging Face, Runway, Recursion Pharmaceuticals, CoreWeave, and Ubitus
  • NVIDIA in its:
    • Terminated acquisition of Arm
    • Completed acquisitions of Run:ai, Shoreline, Bright Computing, DeepMap, Oski and other technology companies
  • Perplexity in its acquisitions of Read.cv and CarbonAI
  • Plaid in its acquisition of Cognito
  • Postmates in its US$2.65 billion sale to Uber
  • Planet Labs in its US$2.8 billion business combination with dMY Technology Group IV
  • Square in its acquisition of:
    • Verse Technologies
    • Dessa
    • Eloquent Labs
  • SRS Acquiom in its sale to Lovell Minnick Partners
  • Synaptics on its wireless asset acquisition from Broadcom
  • Upside Foods in its acquisition of Cultured Decadence
  • Vacasa, a Silver Lake portfolio company, in its acquisition of TurnKey Vacation Rentals

Healthcare and Life Sciences

  • Alliance HealthCare Services in connection with the acquisition by Tahoe Investment Group
  • Blue Sprig Holdings on the acquisition of Trumpet Behavioral Health
  • Relievant MedSystems on its acquisition by Boston Scientific
  • Encore Vision in its US$465 million acquisition by Novartis AG
  • Goldman Sachs in its:
    • Acquisition of Center for Social Dynamics
    • Acquisition of Xpress Wellness
    • Investments in Ajax Therapeutics, Alterome Therapeutics, Attovia, Nested Therapeutics, Rapport Therapeutics, and TORL BioTherapeutics Landmark Health in its sale to General Atlantic
    • Investments in Vicebio, Maplight, evolvedMD, Third Arc Bio, and Newleos 
    • Sale of Vicebio and California Skin Institute
  • Hazel Health in its acquisition of BeMe Health
  • Memora Health in its acquisition by Commure
  • Menlo Therapeutics in its US$390.5 million acquisition of Foamix Pharmaceuticals
  • Relypsa in its US$1.5 billion sale to Galenica AG
  • Revolution Medicines in its acquisition of Warp Drive Bio and other strategic transactions

Venture Capital

Saad regularly represents venture capital and private equity firms in connection with private and public investments, acquisitions, and divestitures. His clients include:

  • Andreessen Horowitz
  • Dragoneer Investment Group
  • Eclipse Ventures
  • Goldman Sachs
  • GreatPoint Ventures
  • KKR
  • SoftBank

Emerging Companies and Public Company Representation

Saad advises public companies in corporate governance matters and strategic investments and emerging and growth companies in formation, corporate governance, securities law, and transactional matters. His experience includes advising:

 

  • BlueSprig Pediatrics
  • Boom Supersonic
  • Calysta
  • Center for Social Dynamics
  • Clubfeast
  • CorneaGen
  • CrossoverHealth
  • EchoNous
  • Evergent Technologies
  • Hazel Health
  • Meta
  • Memphis Meats
  • Plaid
  • Salma Health
  • Square
  • Synack
  • Thumbtack
  • Xpress Wellness

Bar Qualification

  • California

Education

  • JD, Columbia University School of Law, 2008
  • BA in Economics, Yale University, 2002